Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inclusion body myositis

S M Chou1

  • 1ALS and Neuromuscular Research Foundation, San Francisco, CA 94115.

Bailliere'S Clinical Neurology
|November 1, 1993
PubMed
Summary
This summary is machine-generated.

Inclusion bodies in Inclusion Body Myositis (IBM) containing beta-amyloid and ubiquitin aid diagnosis. This discovery shifts understanding of IBM pathogenesis, potentially linking it to neurodegenerative processes like Alzheimer's disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Externalised locking compression plate as an alternative to the unilateral external fixator: a biomechanical comparative study of axial and torsional stiffness.

Bone & joint research·2017
Same author

Cannulated versus non-cannulated cancellous screw fixation for femoral neck fractures: a synthetic bone biomechanical study.

Journal of orthopaedic surgery (Hong Kong)·2015
Same author

Effects of frozen storage temperature on the elasticity of tendons from a small murine model.

Animal : an international journal of animal bioscience·2012
Same author

The development of silk fibroin scaffolds using an indirect rapid prototyping approach: morphological analysis and cell growth monitoring by spectral-domain optical coherence tomography.

Medical engineering & physics·2011
Same author

The influence of gripping techniques on the tensile properties of tendons.

Proceedings of the Institution of Mechanical Engineers. Part H, Journal of engineering in medicine·2005
Same author

Enzymatic degradation of nitriles by Klebsiella oxytoca.

Applied microbiology and biotechnology·2005
Same journal

Remyelination in demyelinating disease.

Bailliere's clinical neurology·1999
Same journal

Other immunomodulatory therapies in multiple sclerosis.

Bailliere's clinical neurology·1999
Same journal

Copolymer-1.

Bailliere's clinical neurology·1999
Same journal

Interferon beta 1a.

Bailliere's clinical neurology·1999
Same journal

Treatment of multiple sclerosis with interferon beta 1b.

Bailliere's clinical neurology·1999
Same journal

The cause and management of bladder, sexual and bowel symptoms in multiple sclerosis.

Bailliere's clinical neurology·1999
See all related articles

Area of Science:

  • Neurology
  • Pathology
  • Immunology

Background:

  • Inclusion Body Myositis (IBM) is a complex clinicopathological entity primarily affecting the elderly.
  • IBM presents with progressive proximal and distal muscle weakness, often refractory to standard treatments.
  • Distinguishing IBM from other myopathies relies on a combination of clinical and pathological findings.

Purpose of the Study:

  • To explore novel diagnostic markers for Inclusion Body Myositis.
  • To elucidate the underlying pathogenesis of IBM and its related disorders.
  • To differentiate IBM from other inflammatory myopathies.

Main Methods:

  • Histopathological analysis of muscle biopsies.
  • Immunohistochemical staining for beta-amyloid and ubiquitin.

Related Experiment Videos

  • Electromyography and clinical assessment.

    • Main Results:

    • Eosinophilic inclusions immunoreactive for beta-amyloid and ubiquitin in myofibers facilitate IBM diagnosis.
    • Diagnostic criteria for IBM are collective, integrating clinical and pathological data.
    • Pathogenesis of IBM may involve chronic intracytoplasmic synthesis of abnormal amyloid protein, similar to Alzheimer's disease.

    Conclusions:

    • Beta-amyloid and ubiquitin identification offers a new diagnostic approach for IBM.
    • The pathogenesis of IBM may differ from other IBMDs, with potential links to neurodegenerative mechanisms.
    • Further research is needed to clarify the role of amyloidogenic filaments and potential viral involvement.